This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Redwood Pharma Management

Management criteria checks 1/4

Redwood Pharma's CEO is MV Vidaeus, appointed in Jan 2012, has a tenure of 12.58 years. directly owns 0.93% of the company’s shares, worth SEK29.18K. The average tenure of the management team and the board of directors is 10.6 years and 0.8 years respectively.

Key information

MV Vidaeus

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure12.6yrs
CEO ownership0.9%
Management average tenure10.6yrs
Board average tenureless than a year

Recent management updates

Recent updates

Is Redwood Pharma (NGM:REDW) In A Good Position To Invest In Growth?

Apr 09
Is Redwood Pharma (NGM:REDW) In A Good Position To Invest In Growth?

CEO

MV Vidaeus (58 yo)

12.6yrs

Tenure

Mr. Martin Vidaeus, also known as MV, MBA, is the Founder of Redwood Pharma AB. Mr. Vidaeus holdss many year's experience in life science business development in the US and Europe. He has successful histor...


Leadership Team

NamePositionTenureCompensationOwnership
Ulf Bjorklund
Chairman & Chief Medical Officerless than a yearno data0.062%
SEK 1.9k
Martin Vidaeus
Founder12.6yrsno data0.93%
SEK 29.2k
Hans Ageland
Founder & COO12.6yrsno data0.15%
SEK 4.8k
Peter Rooslien
Chief Financial Officer8.3yrsno datano data

10.6yrs

Average Tenure

65.5yo

Average Age

Experienced Management: REDW's management team is seasoned and experienced (10.6 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Ulf Bjorklund
Chairman & Chief Medical Officerless than a yearno data0.062%
SEK 1.9k
Martin Vidaeus
Founder12.6yrsno data0.93%
SEK 29.2k
Tom Ronnlund
Independent Directorless than a yearno datano data
Hakan Magnusson
Independent Directorless than a yearno datano data

0.8yrs

Average Tenure

58yo

Average Age

Experienced Board: REDW's board of directors are not considered experienced ( 0.8 years average tenure), which suggests a new board.